B. Detournay

3.4k total citations · 1 hit paper
132 papers, 2.2k citations indexed

About

B. Detournay is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Economics and Econometrics. According to data from OpenAlex, B. Detournay has authored 132 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Endocrinology, Diabetes and Metabolism, 44 papers in General Health Professions and 24 papers in Economics and Econometrics. Recurrent topics in B. Detournay's work include Diabetes Treatment and Management (48 papers), Diabetes Management and Research (41 papers) and Healthcare Systems and Practices (30 papers). B. Detournay is often cited by papers focused on Diabetes Treatment and Management (48 papers), Diabetes Management and Research (41 papers) and Healthcare Systems and Practices (30 papers). B. Detournay collaborates with scholars based in France, United Kingdom and Spain. B. Detournay's co-authors include Abdul Jabbar, Ibrahim Salti, Bruno Guerci, Corinne Emery, Gérard de Pouvourville, C. Pribil, Ronan Roussel, Jean‐Pierre Riveline, Éric Vicaut and Fleur Levrat‐Guillen and has published in prestigious journals such as Diabetes Care, Diabetes and International Journal of Obesity.

In The Last Decade

B. Detournay

122 papers receiving 2.1k citations

Hit Papers

A Population-Based Study of Diabetes and Its Characterist... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries
    2004 557 citations B. Detournay et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Detournay France 23 974 705 256 229 218 132 2.2k
Paul Rheeder South Africa 24 745 0.8× 214 0.3× 183 0.7× 515 2.2× 189 0.9× 120 2.0k
Andrew D. Morris United Kingdom 16 819 0.8× 182 0.3× 250 1.0× 283 1.2× 149 0.7× 26 2.0k
Alexander Kutz Switzerland 29 438 0.4× 552 0.8× 409 1.6× 965 4.2× 127 0.6× 108 2.7k
Thomas M. Richards United States 18 551 0.6× 237 0.3× 497 1.9× 340 1.5× 218 1.0× 34 1.7k
Avis J. Thomas United States 19 425 0.4× 565 0.8× 1.0k 4.0× 211 0.9× 202 0.9× 34 2.3k
Pawana Sharma United Kingdom 19 358 0.4× 213 0.3× 295 1.2× 190 0.8× 111 0.5× 34 1.6k
Patricia Montague Canada 6 410 0.4× 196 0.3× 219 0.9× 287 1.3× 269 1.2× 9 1.8k
Emma Barron United Kingdom 17 1.0k 1.1× 134 0.2× 306 1.2× 291 1.3× 241 1.1× 34 2.2k
Jamie P. Traynor United Kingdom 22 448 0.5× 118 0.2× 361 1.4× 213 0.9× 81 0.4× 69 2.0k
Jawad Al‐Lawati Oman 24 720 0.7× 287 0.4× 197 0.8× 432 1.9× 106 0.5× 81 2.0k

Countries citing papers authored by B. Detournay

Since Specialization
Citations

This map shows the geographic impact of B. Detournay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Detournay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Detournay more than expected).

Fields of papers citing papers by B. Detournay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Detournay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Detournay. The network helps show where B. Detournay may publish in the future.

Co-authorship network of co-authors of B. Detournay

This figure shows the co-authorship network connecting the top 25 collaborators of B. Detournay. A scholar is included among the top collaborators of B. Detournay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Detournay. B. Detournay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gourdy, Pierre, Patrice Darmon, Isabelle Borget, et al.. (2024). Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study. Diabetes Therapy. 15(6). 1349–1360.
2.
Riveline, Jean‐Pierre, Fleur Levrat‐Guillen, B. Detournay, et al.. (2024). Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre ® System Initiation in Some People With Type 2 Diabetes on Insulin-Secretagogue Oral Drug Therapy Without Insulin in France. Diabetes Technology & Therapeutics. 26(12). 932–938. 2 indexed citations
3.
Dardari, Dured, et al.. (2023). Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study. The Lancet Regional Health - Europe. 32. 100686–100686. 12 indexed citations
4.
Guerci, Bruno, Fleur Levrat‐Guillen, Éric Vicaut, et al.. (2023). Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France. Diabetes Technology & Therapeutics. 25(6). 384–394. 18 indexed citations
5.
6.
Riveline, Jean‐Pierre, Ronan Roussel, Éric Vicaut, et al.. (2022). Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study. Diabetes Technology & Therapeutics. 24(9). 611–618. 41 indexed citations
7.
Darmon, Patrice, B. Bauduceau, L. Bordier, et al.. (2021). Prise de position de la Société Francophone du Diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 – 2021. Médecine des Maladies Métaboliques. 15(8). 781–801. 3 indexed citations
8.
Goudemand, Jenny, et al.. (2021). Costs and management of patients with hemophilia A in France: the Hemraude study. The European Journal of Health Economics. 23(1). 23–32. 6 indexed citations
9.
Franc, Sylvia, H. Hanaire, Pierre‐Yves Benhamou, et al.. (2020). DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen. Diabetes Technology & Therapeutics. 22(12). 904–911. 20 indexed citations
10.
Jeandidier, N., Lucy Chaillous, Sylvia Franc, et al.. (2018). DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Research Protocols. 7(4). e66–e66. 13 indexed citations
11.
Detournay, B., et al.. (2018). Clinical added value of drugs: An empirical survey of French transparency committee opinions. Therapies. 76(6). 639–645. 1 indexed citations
12.
Guerci, Bruno, et al.. (2017). [Self-monitoring of blood glucose in France: data from a national survey].. PubMed. 29(2). 229–240. 2 indexed citations
13.
Balkau, Beverley, et al.. (2017). The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study. Diabetes Therapy. 8(5). 1147–1162. 1 indexed citations
14.
Charbonnel, B, Dominique Simon, Jean Dallongeville, et al.. (2017). Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. PharmacoEconomics - Open. 2(2). 209–219. 32 indexed citations
15.
Hanaire, H., C. Attali, D. Gouet, et al.. (2016). [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization].. PubMed. 28(6). 781–789. 4 indexed citations
16.
17.
18.
Robert, Jacques, Candice Roudier, A. Fagot‐Campagna, et al.. (2009). Health care of persons with type 2 diabetes in France in 2007 and trends compared to 2001.. 455–460. 4 indexed citations
19.
Ricci, Paolo, et al.. (2009). Reimbursed health expenditures of people treated for diabetes by the French National Health Insurance Fund: 2001 and 2007 ENTRED Surveys.. 464–469. 4 indexed citations
20.
Detournay, B., F Vauzelle-Kervroëdan, Marie‐Aline Charles, et al.. (1999). [Epidemiology, management and costs of type 2 diabetes in France in 1998].. PubMed. 25(4). 356–65. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Rheeder Breakdown of academic impact, for papers by Andrew D. Morris Breakdown of academic impact, for papers by Alexander Kutz Breakdown of academic impact, for papers by Thomas M. Richards Breakdown of academic impact, for papers by Avis J. Thomas Breakdown of academic impact, for papers by Pawana Sharma Breakdown of academic impact, for papers by Patricia Montague Breakdown of academic impact, for papers by Emma Barron Breakdown of academic impact, for papers by Jamie P. Traynor Breakdown of academic impact, for papers by Jawad Al‐Lawati
Rankless by CCL
2026